Question 1

What is the BPC-157 dose per kilogram of body weight — say, for a 200 lb man?

Accepted Answer

There is no such dose, and the arithmetic used to produce one is invalid. Every µg/kg figure in circulation for BPC-157 is a rat figure. Interspecies dosing is not a multiplication: the FDA's own method normalises to body surface area rather than body weight, so a rat dose in mg/kg is divided by 6.2 and a mouse dose by 12.3 before it is anywhere near a human figure. That method then applies only to a no-observed-adverse-effect level taken from a formal toxicology study, and the result is divided again by a safety factor of at least ten to give a maximum recommended starting dose — the first amount ever given to a human, deliberately set below the dose expected to do anything. BPC-157 has no published toxicology NOAEL and no human pharmacokinetics, so there is nothing to put into the formula at either end. A site that scales it to your body weight has invented the number.

Question 2

Is there a BPC-157 dosage chart?

Accepted Answer

Not an honest one. A dosage chart needs an established human dose to build its rows from, and none exists for any indication. The charts circulating online are community convention repeated until repetition made it look like data; none of them cites a study, because there is no study to cite. What this page gives you instead is the volume maths for the vial actually in front of you, which is a measurement problem and carries no dosing claim.

Question 3

What is the correct BPC-157 dose?

Accepted Answer

No honest source can give you one. A 2026 review in the American Journal of Sports Medicine, written for orthopaedic surgeons whose patients keep asking, concluded that information on indications, dosing, frequency and duration remains unknown. USADA puts it more directly: because BPC-157 has not been extensively studied in humans, it is unknown whether there is a safe dose.

Question 4

Has BPC-157 ever been given to humans in a published study?

Accepted Answer

Barely. The only clinical publication a 2025 systematic review could find is a retrospective chart review of 17 patients who had received knee injections at a single Florida clinic, followed up by telephone, with no control group and no dose recorded. Beyond that there is a 2015 phase 1 study of oral tablets that never reported results, an ulcerative colitis programme that reviews describe as reaching phase 2 but which was never published in full, and a phase 1 trial in rotator cuff repair registered by the University of Arkansas with a 2027 start date. Registry listings are submitted by sponsors and are not themselves evidence that a trial ran, or that a dose in one was safe.

Question 5

How many units or millilitres is a BPC-157 dose?

Accepted Answer

That depends only on your own vial, and it is a volume question rather than a dosing one. A 5 mg vial with 2.5 mL of bacteriostatic water is 2 mg/mL, so 250 mcg is 0.125 mL — 12.5 units on a U-100 syringe. The same 5 mg in 5 mL is 1 mg/mL and doubles every unit count to 25. A 10 mg vial in 2.5 mL is 4 mg/mL and halves it to 6.25. The water changes what you read on the barrel and nothing else. The calculator above solves it in either direction, including backwards from a unit mark you can actually see.

Question 6

Is BPC-157 still FDA Category 2?

Accepted Answer

No — and this is the most commonly wrong claim about it. It was removed from Category 2 on 22 April 2026 after the nominators withdrew their nominations. It was not moved to Category 1: on the FDA's Category 2 page it now appears only under substances “nominated but withdrawn”, and it is absent from all three categories of the nominated-substances list. Being on no list leaves it still failing the statutory conditions for compounding. The July 2026 advisory committee vote recommending it is non-binding and changed nothing legally.

Question 7

What is BPC-157's half-life?

Accepted Answer

Not published for humans. The only pharmacokinetic study of BPC-157 was done in rats and beagle dogs; it found an elimination half-life for the intact peptide of under 30 minutes, with intramuscular bioavailability of roughly 14–19% in rats and 45–51% in dogs. Those are animal figures, and half-life is among the parameters that differ most between species, so they are not a human number. Any specific human half-life quoted elsewhere has no primary source behind it.

BPC-157 Dosage Calculator

Not approved, and not lawfully compoundable

Set up your vial

Key facts

Doses used in published studies

How good is the evidence?

Common questions

Sources